A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients-Reference-Cited by-同舟云学术

A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients

Published:2016-12-20 Issue:10 Volume:127 Page:864-872
ISSN:0020-7454
Container-title:International Journal of Neuroscience
language:en
Short-container-title:International Journal of Neuroscience

Author:

Debs Rabab¹²,Reach Pauline¹²,Cret Corina³,Demeret Sophie²,Saheb Samir⁴,Maisonobe Thierry¹²,Viala Karine¹²

Affiliation:

1. Département de Neurophysiologie, Groupe Hospitalier Pitié-Salpêtriére, AP-HP, Paris, France

2. Service de neurologie 1, Centre diagnostique et thérapeutique des neuropathies périphériques, Groupe Hospitalier Pitié-Salpêtriére, AP-HP, Paris, France

3. Neurology Department, Centre Hospitalier de Meaux, Meaux, France

4. Centre Clinique d'Hémobiothérapie, service d'Hématologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France

Publisher

Informa UK Limited

Subject

General Medicine,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/00207454.2016.1269328

Reference40 articles.

1. IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results

2. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

3. Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous immunoglobulins (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIDP): A comprehensive systematic review of clinical studies and meta-analysis;Neurological Sciences;2024-06-28

2. Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt/mTOR/NF‐κB signaling;Brain and Behavior;2023-03-14

3. High-dose immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis;eNeurologicalSci;2022-06

4. Contemporary challenges in the diagnosis and management of chronic inflammatory demyelinating polyneuropathy;Expert Review of Neurotherapeutics;2022-02-01

5. CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention;Immuno;2022-01-21